CDEK
← All organizations

Heidelberg ImmunoTherapeutics GmbH

For profitWebsite ↗

Also known as: Heidelberg ImmunoTherapeutics GmbH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Nov 15, 2019

Last known activity

Oct 8, 2020

Defunct as of Dec 19, 2021

Timeline

2010s

  1. Jan 1, 2016

    Heidelberg ImmunoTherapeutics GmbH— Founded

2020s

  1. Dec 19, 2021

    Heidelberg ImmunoTherapeutics GmbH— Defunct

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

Details

Founded
DE Jan 1, 2016
Last known activity
Oct 8, 2020